MedPath

Alexion Europe SAS

🇫🇷France
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

32

EMA:11
CIMA_AEMPS:10
SFDA:8
+1 more agencies

Drug Approvals

Ravulizumab Injection

Product Name
伟立瑞
Approval Number
国药准字SJ20250016
Approval Date
Apr 15, 2025
NMPA

Ravulizumab Injection

Product Name
伟立瑞
Approval Number
国药准字SJ20250015
Approval Date
Apr 15, 2025
NMPA

Eculizumab Injection

Product Name
舒立瑞
Approval Number
国药准字SJ20180023
Approval Date
Jul 17, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.